INACTIVATED POLIOMYELITIS VACCINE (DIPLOID CELL ORIGIN) - IPV
INACTIVATED POLIOMYELITIS VACCINE (DIPLOID CELL ORIGIN) - IPV
Discontinued
DIN Number
02231267
Drug Class
Human
Market Date
Nov 17, 1998
Company
HC
Sanofi Pasteur Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02231267
AIG Number0332952002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BF03 POLIOMYELITIS, TRIVALENT, INACTIVATED, WHOLE VIRUS
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEYActive
Strength: 40 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1Active
Strength: 8 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETTActive
Strength: 32 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT